4D Molecular Therapeutics Strengthens Leadership Team with Key Appointments in Clinical …,

Previously, he was Senior Vice President, Clinical Development, at InterMune (acquired by Roche), where he led the final pivotal trial of pirfenidone ( …, Previously, he was Senior Vice President, Clinical Development, at InterMune (acquired by Roche), where he led the final pivotal trial of pirfenidone ( …, Read More

Scroll to Top